Showing results (231-240 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|March 4, 2021
Demonstrating the effect of SHP2 inhibitor on cervical squamous cell carcinoma from the perspective of ZAP70Ming Gong, Peng Liu, Tianyu He, et al.Anti-Cancer Drugs|March 6, 2021
Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinibRoberta Minari, Alessandro Leonetti, Letizia Gnetti, et al.Anti-Cancer Drugs|June 7, 2011
Triterpenoid pristimerin synergizes with taxol to induce cervical cancer cell death through reactive oxygen species-mediated mitochondrial dysfunctionDa-Young Eum, Joo-Yun Byun, Chang-Hwan Yoon, et al.Anti-Cancer Drugs|June 7, 2011
Effect of a photoactivated rhodium complex in melanomaMi Ran Kim, Harry Morrison, Sulma Ibrahim MohammedAnti-Cancer Drugs|April 30, 2011
Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberine-induced apoptosis in human melanoma cellsAna Burgeiro, Consuelo Gajate, El Habib Dakir, et al.Anti-Cancer Drugs|April 21, 2011
Electrochemotherapy for primary skin cancer and skin metastasis related to other malignanciesUwe ReinholdAnti-Cancer Drugs|April 20, 2011
Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cellsChe Chen, Yingmei Zhang, Yong Wang, et al.Anti-Cancer Drugs|June 29, 2011
Design issues in head and neck clinical trials: a statistician's perspectiveCatherine Fortpied, Cecilia Liberatoscioli, Jan BogaertsAnti-Cancer Drugs|June 4, 2011
An in-vitro evaluation of the polo-like kinase inhibitor GW843682X against paediatric malignanciesKristina Spaniol, Joachim Boos, Claudia Lanvers-KaminskyAnti-Cancer Drugs|September 10, 2015
Challenges in the implementation of trastuzumab biosimilars: an expert panel's recommendationsXavier Pivot, Gilles Aulagner, Jean Yves Blay, et al.Pageof 464